Soligenix has scrapped its cutaneous T-cell lymphoma program in the wake of a phase 3 setback, leaving the biotech focused on ...

The City of Pittsfield's Department of Community Development Recreation Program announces the return of the Summer Playground ...

The app is partnering with Sundance Institute to help train the next generation of filmmakers on how to create a short-form narrative series.

Development Partner Torii Pharmaceutical also recently announced dosing of the first Japanese patient in this trial evaluating YCANTH (TO-208) ...

At the center of AIM's strategy is Ampligen ® (rintatolimod), the Company's proprietary TLR3 agonist immunotherapy, which is being evaluated in the ongoing Phase 2 DURIPANC study in combination with ...

Researchers discover that the GPR3 receptor acts as an immediate-early gene to jumpstart neuron and synapse development.

The Centers for Medicare and Medicaid Services (CMS) is launching a pilot program on July 1 to subsidize costs of GLP-1s ...

The state sued Step Up on Second and other organizations in January 2024 alleging fraud related to the Homekey program.

The Environment and Sustainable Development 5 Minute Fix is your quick update on key ESD developments across Australia. This edition covers new Commonwealth exposure draft National Environmental ...

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera’s plan to ...

Silence Therapeutics plc Buy: siRNA progress in PV & ASCVD, divesiran SANRECO data and Aug 2026 catalyst; watch cash runway/ATM dilution - click for more on SLN.